Упрощенная HTML-версия
139
139.
Lipid-lowering drug use and breast cancer in older women: a prospective
study / J. A. Cauley [et al.] // J. Womens Health (Larchmt). – 2003. – Vol.
12. – P. 749-756.
140.
Losartan and simvastatin inhibit platelet activation in hypertensive patients
/ S. Nomura [et al.] // J. Thromb. Thrombolysis. – 2004. – Vol. 18, № 3. –
P. 177-185.
141.
Lovastatin induces a pronounced differentiation response in acute myeloid
leukemias / J. Dimitroulakos [et al.] // Leuk. Lymphoma. – 2000. – Vol. 40.
– P. 167-178.
142.
Lovastatin-induced apoptosis in human melanoma cell lines / Y. G. Shell-
man [et al.] // Melanoma Res. – 2005. – Vol. 15. – P. 83-89.
143.
Manipulating the angiotensin system-new approaches to the treatment of
solid tumours / K. Ino [et al.] // Expert Opin. Biol. Ther. – 2006. – Vol. 6,
№ 3. – P. 243-255.
144.
Metformin is an AMPkinase-dependent growth inhibitor for breast cancer
cells / M. Zakikhani [et al.] // Cancer Res. – 2006. – Vol. 66. – P. 10269-
10273.
145.
Monitoring left ventricular function in adults receiving antracycline–
containing chemotherapy / M. Belham [et al.] // Eur. J. Heart Fail. – 2007.
– Vol. 9, № 4. – P. 409-414.
146.
Native and reconstituted HDL protect cardiomyocytes from doxorubicin-
induced apoptosis / M. A. Frias [et al.] // Cardiovasc. Res. – 2010. – Vol.
85, № 1. – P. 118-126.
147.
Navarro V. J. Drug-Related Hepatotoxicity / V. J. Navarro, J. R. Senior //
N. Engl. J. Med. – 2006. – Vol. 354, № 7. – Р. 731-739.
148.
Nox-2 NADPH oxidase promotes pathologic cardiac remodeling associated
with doxorubicin chemotherapy / Y. Zhao [et al.] // Cancer Res. – 2010. –
Vol. 70, № 22. – P. 9287-9297.